KLEO PHARMACEUTICALS INC has a total of 14 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are ASKGENE PHARMA INC, CANCER INST and WEIDANZ JON A.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Australia | 1 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Philippines | 1 | |
#10 | Singapore | 1 | |
#11 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Welsch Matthew Ernest | 11 |
#2 | Spiegel David Adam | 10 |
#3 | Bunin Anna | 3 |
#4 | Rastelli Luca | 2 |
#5 | Iben Lawrence G | 1 |
#6 | David Adam Spiegel | 1 |
#7 | Rossi Ann Marie K | 1 |
#8 | Berbasova Tetyana | 1 |
#9 | Manion Douglas | 1 |
#10 | Matthew Ernest Welsch | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021003050A2 | Cd38-binding agents and uses thereof | |
WO2020132588A1 | Combination therapy of arms and natural killer cells | |
WO2019136442A1 | Cd16a binding agents and uses thereof | |
BR112020001583A2 | universal abt compounds and their uses |